P3.18.41 A Phase II Study of Second-Line Cadonilimab, Bevacizumab and Docetaxel in Patients With Advanced NSCLC
Back to course
Asset Subtitle
Jian Chun Duan
Meta Tag
Speaker Jian Chun Duan
Topic Clinical Trials in Progress
Powered By